Current Companies in Residence
at the Canadian Technology Accelerator in Boston - CTA@Boston
Cyclica develops better and safer pharmaceutical drugs, nutraceuticals ingredients, and personal care products through computational insights.
ExVivo Labs is developing a non-invasive skin patch to test for allergies, making allergy testing safe, simple and certain.
KalGene Pharmaceuticals is developing disease modifying novel therapeutics for Alzheimer’s.
NutraEx provides great tasting natural sugar substitutes to consumers and food manufacturers. Zero Calories, Zero Compromise.
viDA Therapeutics is developing a library of first in class serine protease inhibitors focusing on a new mechanism of action for extracellular Granzyme B in chronic inflammatory, autoimmune, and age-related indications.
>>More about viDA Therapeutics
XLV Diagnostics Inc., a medical imaging equipment company, is developing, manufacturing and commercializing the X-ray Light Valve (XLV) technology to make economical x-ray detectors for digital radiology machines to be used for early cancer detection and treatment.